The shape of clinical literature
The mass of published literature now far exceeds our ability to cope with it as individuals; the evidence for practice is out there but in blinding volume and a bewildering array of formats and platforms. Experienced clinicians in the past have tended to choose one or two principal sources of information, often old friends like PubMed, a general journal like BMJ or the New England Journal of Medicine, plus two or three journals in their specialty – say, Urology, BJU International or European Urology – and stick with them. This is no longer sufficient to allow a practitioner to keep up with new relevant and applicable clinical research. However, in a very positive turn of events over the past decade, the geometrically growing mass of published clinical research has brought with it the development of resources to synthesize this new knowledge and present it in methodologically sound as well as extremely accessible formats. Armed with these resources and a few relatively simple techniques, it is indeed possible to find evidence for practice quickly and efficiently.
The three general classes of clinical information are (Box 1.1):
- bibliographic databases – indexes to published primary literature, usually journal articles
- selected, often preappraised sources – selections of high-impact primary clinical research, published as databases (such as EvidenceUpdates + or the Cochrane Central Registry of Controlled Trials) or as digest journals (ACP Journal Club, Evidence-based Medicine), which, searched electronically, become like small, select databases
- synthesized sources – including systematic reviews, practice guidelines, textbooks, and point-of-care resources; these gather and critically appraise primary clinical research articles and combine their information into a new entity, often with a focus on accessibility and clinical relevance.
BOX 1.1 Sources of evidence for clinical practice
1. Synthesized sources
a. Point-of-care resources
i. ACP PIER
ii. Clinical Evidence
iii. BMJ Point of Care
iv. Dynamed
b. Textbooks and handbooks
i. ACP Medicine/ACS surgery
ii. E-Medicine (via TRIP) http://www.tripdatabase.com/
iii. Other textbooks—many textbooks are on-line; some are in sets, such as STAT!Ref, MD Consult (includes Campbell’s Urology), Books@OVID, Access Medicine–check textbooks for explicit references, and check the references for clinical research
c. Practice guidelines
i. National Guideline Clearinghouse http://www.guideline.gov/
ii. Clinical Knowledge Summaries http://www.cks.library.nhs.uk/
iii. Via TRIP http://www.tripdatabase.com/
iv. American Urological Association Guidelines http://www.auanet.org/guidelines/
d. Systematic reviews
i. Cochrane Database of Systematic Reviews
ii. DARE (Database of Abstracts of Reviews of Effects)
iii. Medline/PubMed—search systematic reviews in clinical queries.
2. Filtered sources
a. Evidence-based Medicine
b. BMJ Updates + http://bmjupdates.mcmaster.ca
c. Cochrane Central Registry of Controlled Trials
3. Filtering unfiltered sources
a. Clinical Queries—MEDLINE (PubMed, Ovid—under “More limits”)
b. TRIP—one-stop shopping http://www.tripdatabase.com/ (TRIP Medline search uses “clinical queries” filters)
c. Combine search statement with description of most appropriate study design
4. Other therapeutic resources
a. Medicines Complete (Martindales, Stockley’s Drug Interactions)
b. Natural Standard (for herbal and other complementary and alternative therapies)
The approach for finding evidence for practice is exactly opposite to that for conducting a literature search preparatory to conducting a literature review. In the case of the literature review, one conducts a thorough search of the appropriate bibliographic databases – Medline (whether via PubMed or some other search interface), EMBASE, Web of Science, Scopus, Biosis Previews, plus resources such as the Cochrane Library (to ensure one hasn’t missed an important controlled trial or systematic review) or databases of clinical trials in progress, to ensure that all relevant studies have been found. If possible, one consults a research librarian to be sure that no stone has been left unturned. However, to find evidence to apply to clinical problems, the search begins with synthesized resources, progresses through selected, preappraised resources, and only moves into bibliographic databases if no satisfactory answer has been found in the first two resource classes. With a literature review, the search is exhaustive. With the search for applicable clinical evidence, it is acceptable to stop when a good answer has been found.
Some of the resources described are free; most are broadly available to those affiliated with medical societies or institutions or are available by individual subscription. New synthesized resources, point-of-care resources in particular, are emerging rapidly and established resources are continuously evolving. Understanding the elements of evidence-based practice will enable the practitioner to be an enlightened consumer of these resources.
Mr W, 63 years old and otherwise fit and healthy, has been referred to you with symptoms of benign prostatic hyperplasia (BPH) (frequency, nocturia, and slow flow). Digital rectal examination reveals an enlarged prostate gland, about 45 g, with no nodules. His postvoid is approximately 100 cc and he reports three documented urinary tract infections over the course of the last year. His serum creatinine and prostate-specific antigen (PSA) levels are normal.
He has been advised by his family physician that he may require surgery to resolve his condition. He is apprehensive about this and asks if there are medical interventions for the BPH that could be tried first. He has searched the web and has found information that saw palmetto may be an effective herbal remedy to improve his voiding symptoms.
What do you want? Asking a focused clinical question
The first two steps of the protocol of evidence-based practice (Assess, Ask, Acquire, Appraise, Apply) [1] involve assessing the situation – pulling out the salient features of a patient’s presentation and history – and asking one or more questions that are both focused and answerable. Assessing the situation may require some background information about the condition itself – for example, “how does BPH promote voiding complaints?.” To find primary research evidence to apply to the patient at hand, however, a focused, answerable question must be crafted. Asking a focused clinical question is a mental discipline that will also pay off enormously in effective searching and in finding good evidence to apply to practice.
Assigning a domain – therapy/prevention, diagnosis, prognosis, etiology/harm – is the essential first step in framing the question, because questions are asked differently, depending on the domain (Box 1.2). Often questions regarding a single case will fall into multiple domains. In this instance, separate focused questions for each relevant domain will result in clearer answers.
Once the domain has been established, the elements of the focused clinical question must be identified.
- P = Population. The patient’s characteristics, including age, gender, and condition, plus other relevant clinical or medical history features.
- I = Intervention. What intervention are you considering using? In a diagnostic question, this becomes “what new test do I wish to try?.” In a prognostic question, this equates to “prognostic factor” and in the etiology domain, this becomes “exposure.”
- C = Comparison. In the therapy domain, this might be the standard of care or a placebo, where this is appropriate; in diagnosis, the comparison is always the “gold standard” diagnostic test; in the case of a causation/etiology question, this obviously might be “no exposure;” and in prognosis, this might be the lack of the relevant prognostic factor.
- O = Outcome. For therapy, what changes are you looking to accomplish in the patient’s condition? Are they clinical changes, such as the reduction of the number of urinary tract infection (UTI) recurrences? Or are they surrogate, such as reduction in the size of the prostate? In diagnosis, how likely is the new test, in comparison with the gold standard, to predict or rule out the presence of a condition? In a prognostic question – often the most important for the patient – what is the expected disease progression? And in the etiology domain, how closely is this risk factor associated with the condition?
- T = Type of study. What study design will generate the best level of evidence with which to answer this question? This will vary from domain to domain, and also depending upon the subject itself.
BOX 1.2 The well-built clinical question (PICOT)
Therapy
Population (patient)
How would I describe a group of patients similar to mine? (condition, age, gender, etc.)
Intervention (medication, procedure, etc.)
Which main/new intervention am I considering?
Comparison
What is the alternative to compare with the intervention? (placebo, standard of care, etc.)
Outcome
What might I accomplish, measure, improve, or affect?
Type of study
What study design would provide the best level of evidence for this question?
Diagnosis
Population (patient)
What are the characteristics of the patients? What is the condition that may be present?
Intervention (diagnostic test)
Which diagnostic test am I considering?
Comparison
What is the diagnostic gold standard?
Outcome
How likely is the test to predict/rule out this condition?
Type of study
What study design would provide the best level of evidence for this question?
Prognosis
Population (patient)
How would I describe a cohort of patients similar to mine (stage of condition, age, gender, etc.)?
Intervention (prognostic factor)
Which main prognostic factor am I considering?
Comparison (optional)
What is the comparison group, if any?
Outcome
What disease progression can be expected?
Type of study